Western Blotting Market Size Worth USD 958.4 Million By 2025 | Top Companies Are Thermo Fisher Scientific, Inc. & Bio-Rad Laboratories, Inc.

San Francisco, 12 Dec 2018 - Western Blotting Market Analysis By Product (Gel Electrophoresis, Blotting Systems, Imagers, Consumables), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End-Use, And Segment Forecasts, [2018 – 2025]
The western blotting market can be segregated on the basis of product, application, end-use, and region. Growing requirement for effective tests to diagnose human immunodeficiency virus (HIV) in humans is anticipated to propel demand for western blotting. These tests are likely to offer greater accuracy in detecting HIV antibodies in patient’s blood over enzyme-linked immunosorbent assay (ELISA) tests. However, healthcare professionals do prescribe ELISA at first attempt to screen HIV. But, western blot can further help in confirming prevalence of HIV infection in patient’s body. Although, this testing tool is expected to be complicated as compared to ELISA. It can deliver more effective and accurate results in detecting HIV virus.


Increasing use of western blot tests to diagnose Lyme disease with greater and specificity can augment growth of market. Growing R&D investments from biotechnology and pharmaceutical companies, which includes R&D activities requiring western blot tests can fuel market growth. Favorable initiatives from governments worldwide and funding for research in academic institutes is anticipated to influence growth of market. High demand for personalized medicine can fuel market growth during the forecast period (2014 to 2025).

The western blotting market can be segregated on the basis of product, application, end-use, and region. Based on product, the market can be categorized into consumables and instruments. In 2016, consumables segment dominated the market and accounted for largest market share. Growing prevalence of target diseases requiring western blotting for research and diagnosis can fuel growth of segment. In addition, consumables are likely to have widespread usage in western blotting techniques.

Access In-depth Insights On Western Blotting Market:
www.grandviewresearch.com/industry-analysis/western-blotting-market

On the contrary, instruments segment is predicted to witness significant growth during the forecast period owing to availability of automated instruments for conducting western blot. This is likely to help in facilitating rapid diagnostics of chronic diseases.

Based on application, the market can be classified into agriculture, disease diagnostics, biomedical & biochemical research, and others. In 2016, biomedical & biochemical research dominated the market and accounted for largest market share. Growing number of R&D activities being conducted coupled with increasing investments from governments worldwide in research related to proteomics can fuel market growth.

On the contrary, disease segment is estimated to grow fast during the forecast period owing to rising incidence and prevalence of target diseases such as Lyme disease, human immunodeficiency virus (HIV), and Hepatitis B infection.
Based on end-use, the market can be divided into pharmaceutical & biotechnology companies, academic & research institutes, diagnostic centers, and others. In 2016, academic and research institutes dominated the market and accounted for largest market share. Rising number of R&D activities conducted by academic institutes and research centers can fuel market growth. In addition, these activities are likely to be supported by government funding. This, in turn can boost revenue share over the forecast period.

Pharmaceutical & biotechnology companies are predicted to witness lucrative growth during the forecast period attributed to increasing R&D investments by these companies with respect to drug discovery and development can fuel growth. 

Regional segmentation includes Europe, Asia Pacific, Latin America, Middle East & Africa, and North America. In 2015, North America dominated the market and accounted for largest market share. Increasing use of genetically modified crops in United States (U.S.) can fuel market growth. In addition, huge fund generation by government in R&D activities can drive growth of market during the forecast period.

In Asia Pacific, the market is predicted to witness lucrative growth during the forecast period. Growing prevalence of HIV in India and rising R&D investments by Indian government in the field of agriculture can fuel market growth. Moreover, growth of biotechnology sector in China and India can stimulate growth of market in the region over next few years.

Some of the leading companies offering western blotting are Bio-Techne Corporation; GE Healthcare; Merck KGaA; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche Ltd.; and Cell Signaling Technology. Most companies are expected to focus on R&D activities to develop new and innovative products. This, in can support companies in expanding their product portfolio and maintain competitive edge over others. In addition, companies are likely to get involved in business strategies such as mergers and acquisitions to expand their reach.

Grand View Research has segmented the western blotting market on the basis of product, application, end-use and region:

Western Blotting Product Outlook (Revenue, USD Million; 2014 - 2025)
  • Instruments                      
    • Gel Electrophoresis Instruments 
    • Blotting Systems  
      • Semi-Dry Blotting Instruments
      • Wet Blotting Instruments
    • Imagers    
      • Chemiluminescent Imagers
      • Fluorescent Imagers
      • Others
    • Consumables                   
      • Reagents  
      • Kits           
      • Others      
Western Blotting Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Biomedical & Biochemical Research
  • Disease Diagnostics
  • Agriculture
  • Others
Western Blotting End-Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Centers
  • Others
Western Blotting Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information
: www.grandviewresearch.com

1 comment:

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

The global  mHealth apps market  size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, In...